7 results
Primary objective:To compare the effect of ixa+dex versus pom+dex on progression-free survival (PFS) in patients with relapsed and/or refractory multiple myeloma (RRMM) who have received at least 2 prior lines of therapy, including lenalidomide and…
Primary:1) Feasibility: Evidence of targeted lung volume reduction (TLVR) on CT scan at 6 weeks and 3 months follow up after endobronchial valve placement.Secondary:2) Safety: The number and type of procedure-related (Serious) Adverse events within…
Primary• To evaluate the safety of using a modified staged treatment algorithm at 3*months following the second placement of AeriSeal foam treatment in subjects with severe emphysema.Secondary• To evaluate lung function, exercise tolerance and,…
To determine the effect of lidocaine on the main symptoms of COVID-19.
The purpose of this study is to characterize the safety and tolerability of talquetamab when administered in different combination regimens and to identify the safe dose(s) of talquetamab combination regimens.
The primary objective of this study is to compare the efficacy of teclistamab monotherapy (Arm A) with that of an investigator*s choice of PVd or Kd (Arm B: termed PVd/Kd hereafter) as assessed by PFS.
Primary objective:To compare the efficacy with belantamab mafodotin vs pomalidomide plus low dose dexamethasone (pom/dex) in participants with relapsed/refractory multiple myeloma (RRMM)Secondary objectives:- To compare the overall survival with…